In response to DNA damage, a cell can be forced to permanently exit the cell cycle and become senescent. Senescence provides an early barrier against tumor development by preventing proliferation of cells with damaged DNA. By studying single cells, we show that Cdk activity persists after DNA damage until terminal cell cycle exit. This low level of Cdk activity not only allows cell cycle progression, but also promotes cell cycle exit at a decision point in G2 phase. We find that residual Cdk1/2 activity is required for efficient p21 production, allowing for nuclear sequestration of Cyclin B1, subsequent APC/CCdh1 -dependent degradation of mitotic inducers and induction of senescence. We suggest that the same activity that triggers mitosis in an unperturbed cell cycle enforces senescence in the presence of DNA damage, ensuring a robust response when most needed.

Department of Cell and Molecular Biology Karolinska Institutet Stockholm Sweden

Laboratory of Cancer Cell Biology Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A (2008) PCNA‐dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Genes Dev. 22, 2496–2506. PubMed PMC

Akopyan K, Silva Cascales H, Hukasova E, Saurin AT, Mullers E, Jaiswal H, Hollman DA, Kops GJ, Medema RH, Lindqvist A (2014) Assessing kinetics from fixed cells reveals activation of the mitotic entry network at the S/G2 transition. Mol. Cell 53, 843–853. PubMed

Akopyan K, Lindqvist A, Müllers E (2016) Cell cycle dynamics of proteins and post‐translational modifications using quantitative immunofluorescence. Methods Mol. Biol. 1342, 173–183. PubMed

Alvarez‐Fernandez M, Medema RH, Lindqvist A (2010) Transcriptional regulation underlying recovery from a DNA damage‐induced arrest. Transcription 1, 32–35. PubMed PMC

Bartek J, Lukas C, Lukas J (2004) Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5, 792–804. PubMed

Bassermann F, Frescas D, Guardavaccaro D, Busino L, Peschiaroli A, Pagano M (2008) The Cdc14B‐Cdh1‐Plk1 axis controls the G2 DNA‐damage‐response checkpoint. Cell 134, 256–267. PubMed PMC

Baus F, Gire V, Fisher D, Piette J, Dulic V (2003) Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 22, 3992–4002. PubMed PMC

Brown NR, Noble ME, Endicott JA, Johnson LN (1999) The structural basis for specificity of substrate and recruitment peptides for cyclin‐dependent kinases. Nat. Cell Biol. 1, 438–443. PubMed

Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501. PubMed

Cerqueira A, Santamaria D, Martinez‐Pastor B, Cuadrado M, Fernandez‐Capetillo O, Barbacid M (2009) Overall Cdk activity modulates the DNA damage response in mammalian cells. J. Cell Biol. 187, 773–780. PubMed PMC

Charrier‐Savournin FB, Chateau MT, Gire V, Sedivy J, Piette J, Dulic V (2004) p21‐mediated nuclear retention of cyclin B1‐Cdk1 in response to genotoxic stress. Mol. Biol. Cell 15, 3965–3976. PubMed PMC

el‐Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825. PubMed

Fagerland MW (2012) T‐tests, non‐parametric tests, and large studies—a paradox of statistical practice?. BMC Med. Res. Methodol. 12, 1–7. PubMed PMC

Ferretti LP, Lafranchi L, Sartori AA (2013) Controlling DNA‐end resection: a new task for CDKs. Front. Genet. 4, 1–7. PubMed PMC

Fung TK, Poon RYC (2005) A roller coaster ride with the mitotic cyclins. Semin. Cell Dev. Biol. 16, 335–342. PubMed

Gillis LD, Leidal AM, Hill R, Lee PW (2009) p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage. Cell Cycle 8, 253–256. PubMed

Gire V, Dulić V (2015) Senescence from G2 arrest, revisited. Cell Cycle 14, 297–304. PubMed PMC

Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene‐induced DNA damage model for cancer development. Science 319, 1352–1355. PubMed

Hochegger H, Takeda S, Hunt T (2008) Cyclin‐dependent kinases and cell‐cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol. 9, 910–916. PubMed

Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP (2006) ATM‐ and cell cycle‐dependent regulation of ATR in response to DNA double‐strand breaks. Nat. Cell Biol. 8, 37–45. PubMed

Jin P, Gu Y, Morgan DO (1996) Role of inhibitory CDC2 phosphorylation in radiation‐induced G2 arrest in human cells. J. Cell Biol. 134, 963–970. PubMed PMC

Jin P, Hardy S, Morgan DO (1998) Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875–885. PubMed PMC

Johmura Y, Shimada M, Misaki T, Naiki‐Ito A, Miyoshi H, Motoyama N, Ohtani N, Hara E, Nakamura M, Morita A, Takahashi S, Nakanishi M (2014) Necessary and sufficient role for a mitosis skip in senescence induction. Mol. Cell 55, 73–84. PubMed

Johnson N, Cai D, Kennedy RD, Pathania S, Arora M, Li YC, D'Andrea AD, Parvin JD, Shapiro GI (2009) Cdk1 participates in BRCA1‐dependent S phase checkpoint control in response to DNA damage. Mol. Cell 35, 327–339. PubMed PMC

Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D'Andrea AD, Curtin NJ, Wong KK, Shapiro GI (2011) Compromised CDK1 activity sensitizes BRCA‐proficient cancers to PARP inhibition. Nat. Med. 17, 875–882. PubMed PMC

Krenning L, Medema RH (2014) Enter the nucleus to exit the cycle. Cell Cycle 13, 2651–2652. PubMed PMC

Krenning L, Feringa FM, Shaltiel IA, vandenBerg J, Medema RH (2014) Transient activation of p53 in G2 phase is sufficient to induce senescence. Mol. Cell 55, 59–72. PubMed

Lapenna S, Giordano A (2009) Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8, 547–566. PubMed

Lindqvist A, de Bruijn M, Macurek L, Brás A, Mensinga A, Bruinsma W, Voets O, Kranenburg O, Medema RH (2009a) Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression. EMBO J. 28, 3196–3206. PubMed PMC

Lindqvist A, Rodriguez‐Bravo V, Medema RH (2009b) The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell Biol. 185, 193–202. PubMed PMC

Macheret M, Halazonetis TD (2015) DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. Mech. Dis. 10, 425–448. PubMed

Macurek L, Benada J, Mullers E, Halim VA, Krejcikova K, Burdova K, Pechackova S, Hodny Z, Lindqvist A, Medema RH, Bartek J (2013) Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis. Cell Cycle 12, 251–262. PubMed PMC

Maggiorella L, Deutsch E, Frascogna V, Chavaudra N, Jeanson L, Milliat F, Eschwege F, Bourhis J (2003) Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo . Cancer Res. 63, 2513–2517. PubMed

Müllers E, Silva Cascales H, Jaiswal H, Saurin AT, Lindqvist A (2014) Nuclear translocation of cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase. Cell Cycle 13, 2733–2743. PubMed PMC

Myers JS, Zhao R, Xu X, Ham AJ, Cortez D (2007) Cyclin‐dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2‐M checkpoint response to DNA damage. Cancer Res. 67, 6685–6690. PubMed PMC

Nakayama Y, Yamaguchi N (2013) Role of cyclin B1 levels in DNA damage and DNA damage‐induced senescence. Int. Rev. Cell. Mol. Biol. 305, 303–337. PubMed

Niculescu AB III, Chen X, Smeets M, Hengst L, Prives C, Reed SI (1998) Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629–643. PubMed PMC

Ou Y‐H, Chung P‐H, Sun T‐P, Shieh S‐Y (2005) p53 C‐terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA‐damage‐induced C‐terminal acetylation. Mol. Biol. Cell 16, 1684–1695. PubMed PMC

Spencer SL, Cappell SD, Tsai FC, Overton KW, Wang CL, Meyer T (2013) The proliferation‐quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 155, 369–383. PubMed PMC

Stern B, Nurse P (1996) A quantitative model for the cdc2 control of S phase and mitosis in fission yeast. Trends Genet. 12, 345–350. PubMed

Tian B, Yang Q, Mao Z (2009) Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat. Cell Biol. 11, 211–218. PubMed PMC

Uhlmann F, Bouchoux C, López‐Avilés S (2011) A quantitative model for cyclin‐dependent kinase control of the cell cycle: revisited. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366, 3572–3583. PubMed PMC

Wiebusch L, Hagemeier C (2010) p53‐ and p21‐dependent premature APC/C‐Cdh1 activation in G2 is part of the long‐term response to genotoxic stress. Oncogene 29, 3477–3489. PubMed

Yata K, Esashi F (2009) Dual role of CDKs in DNA repair: to be, or not to be. DNA Repair 8, 6–18. PubMed

Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1

Persistent repair intermediates induce senescence